AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff

For 2022, AbbVie granted Gonzalez a pay package worth $26.3 million, an increase of nearly 10% over his 2021 compensation, a securities filing shows.

Big jumps in equity awards more than offset slumps in cash incentive payments and pension value for Gonzalez. AbbVie’s board praised its chairman and CEO for driving “top-tier business performance.”